Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era
Open Access
- 21 July 2022
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (14) , 4249
Abstract
Acute liver failure (ALF) and acute-on-chronic liver failure (ACLF), respectively, occur in patients with normal liver and patients with chronic liver diseases, including cirrhosisKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP22fk0210075h0003)
This publication has 27 references indexed in Scilit:
- Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory SignalsJournal of Clinical Medicine, 2021
- Acute-on-Chronic Liver Failure in CirrhosisJournal of Clinical Medicine, 2021
- Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-AnalysisJournal of Clinical Medicine, 2021
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseHepatology International, 2020
- Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver FailureJournal of Clinical Medicine, 2020
- Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an updateHepatology International, 2019
- Liver function assessment according to the Albumin–Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinomaInvestigational New Drugs, 2015
- Lipopolysaccharide blocks induction of unfolded protein response in human hepatoma cell linesImmunology Letters, 2013
- Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases.2005
- Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan.2004